1-215741541-GAA-GAAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong
The NM_206933.4(USH2A):c.11549-5dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0432 in 928,684 control chromosomes in the GnomAD database, including 2 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00094 ( 1 hom., cov: 32)
Exomes 𝑓: 0.051 ( 1 hom. )
Consequence
USH2A
NM_206933.4 splice_region, intron
NM_206933.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.396
Publications
4 publications found
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A Gene-Disease associations (from GenCC):
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosa 39Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP6
Variant 1-215741541-G-GA is Benign according to our data. Variant chr1-215741541-G-GA is described in ClinVar as Benign. ClinVar VariationId is 198307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| USH2A | NM_206933.4 | c.11549-5dupT | splice_region_variant, intron_variant | Intron 59 of 71 | ENST00000307340.8 | NP_996816.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| USH2A | ENST00000307340.8 | c.11549-5_11549-4insT | splice_region_variant, intron_variant | Intron 59 of 71 | 1 | NM_206933.4 | ENSP00000305941.3 | |||
| USH2A | ENST00000674083.1 | c.11549-5_11549-4insT | splice_region_variant, intron_variant | Intron 59 of 72 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.000931 AC: 129AN: 138634Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
129
AN:
138634
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0572 AC: 6751AN: 118084 AF XY: 0.0557 show subpopulations
GnomAD2 exomes
AF:
AC:
6751
AN:
118084
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0507 AC: 40031AN: 789990Hom.: 1 Cov.: 33 AF XY: 0.0506 AC XY: 19779AN XY: 391068 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
40031
AN:
789990
Hom.:
Cov.:
33
AF XY:
AC XY:
19779
AN XY:
391068
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1015
AN:
17546
American (AMR)
AF:
AC:
1679
AN:
26130
Ashkenazi Jewish (ASJ)
AF:
AC:
882
AN:
12634
East Asian (EAS)
AF:
AC:
1227
AN:
20872
South Asian (SAS)
AF:
AC:
2810
AN:
44120
European-Finnish (FIN)
AF:
AC:
1666
AN:
29874
Middle Eastern (MID)
AF:
AC:
133
AN:
3754
European-Non Finnish (NFE)
AF:
AC:
28855
AN:
602988
Other (OTH)
AF:
AC:
1764
AN:
32072
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.244
Heterozygous variant carriers
0
6590
13181
19771
26362
32952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
968
1936
2904
3872
4840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000937 AC: 130AN: 138694Hom.: 1 Cov.: 32 AF XY: 0.00108 AC XY: 72AN XY: 66854 show subpopulations
GnomAD4 genome
AF:
AC:
130
AN:
138694
Hom.:
Cov.:
32
AF XY:
AC XY:
72
AN XY:
66854
show subpopulations
African (AFR)
AF:
AC:
17
AN:
37918
American (AMR)
AF:
AC:
12
AN:
13946
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3288
East Asian (EAS)
AF:
AC:
0
AN:
4784
South Asian (SAS)
AF:
AC:
2
AN:
4438
European-Finnish (FIN)
AF:
AC:
41
AN:
7696
Middle Eastern (MID)
AF:
AC:
0
AN:
268
European-Non Finnish (NFE)
AF:
AC:
56
AN:
63614
Other (OTH)
AF:
AC:
2
AN:
1898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Dec 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Usher syndrome type 2A Benign:2
Sep 25, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
Aug 29, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Retinitis pigmentosa 39 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.